Ongoing CE Activities

NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025

Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma

Updates to Management of Multiple Myeloma

Transitioning CAR T-Cell and Bispecific Therapies to the Outpatient Setting

Navigating the Storm of Heavily Pretreated Multiple Myeloma: Calming the Waters With Bispecific Antibodies

Novel and Emerging Treatment Approaches for Newly Diagnosed Multiple Myeloma

Multiple Myeloma and Myeloid Malignancies Highlights – Summer 2025

Optimizing Care Coordination for Seamless Integration of CAR T-Cell Therapy in Earlier Lines of MM Treatment

Expert Strategies to Optimize the Integration of CAR T-Cell Therapy Into Earlier Lines of Multiple Myeloma Treatment